Nicholas Piramal Setting Up Nationwide Drug Distribution Network
This article was originally published in PharmAsia News
Over the next two years, Nicholas Piramal India plans to establish a network connecting 100,000 remote Indian villages to supply drugs. Less than a third of India's population currently has access to modern drugs because of a lack of physicians and stores. The Nicholas network would connect health workers in the villages to doctors in the firm's network for prescribing drugs. The company also sells diagnostics services, which also would be involved in the network. (Click here for more
You may also be interested in...
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.